person
Raúl C. M.
- Country
- Spain
- Department
- Hematology
Research Overview
assignment
11
Clinical Trials ·
- A Phase 2 Open-label Study of Loncastuximab Tesirine in Combination with Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Patients with Diffuse Large B-cell Lymphoma (DLBCL) (LOTIS-9)
- Phase I/II Study on Safety and Efficacy of AZD5492 as Monotherapy and in Combination for Relapsed/Refractory B-Cell Malignancies
- Phase 2 Evaluation of Nanatinostat and Valganciclovir in Epstein-Barr Virus-Positive Relapsed/Refractory Lymphomas
location_city
1
Research Sites
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
46
Sites with multiple studies
Has run more than one trial at 46 of 160 partner sites.
Specializations
B-Cell Lymphomas
Specializes in therapeutic approaches for diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma, with particular focus on novel antibody combinations and targeted therapies.
- First-line treatment strategies
- Relapsed/refractory disease management
- Immunotherapy combinations
T-Cell Lymphomas
Conducts research in peripheral T-cell lymphoma and related subtypes, investigating innovative therapeutic combinations and novel agents.
- Novel drug development
- Combination therapy approaches
- Treatment resistance mechanisms
Chronic Lymphocytic Leukemia
Focuses on advancing treatment options for chronic lymphocytic leukemia (CLL), particularly through targeted therapies and novel drug combinations.
- BTK inhibitor therapies
- Venetoclax-based combinations
- Treatment sequencing strategies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.